Literature DB >> 16127291

Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.

Ujjal K Bhawal1, Yoshie Ozaki, Masahiro Nishimura, Masaru Sugiyama, Tomonori Sasahira, Yuji Nomura, Fuyuki Sato, Katsumi Fujimoto, Nobuyuki Sasaki, Masa-Aki Ikeda, Koichiro Tsuji, Hiroki Kuniyasu, Yukio Kato.   

Abstract

OBJECTIVES: The receptor for advanced glycation end products (RAGE) is a newly recognized factor regulating cancer cell invasion and metastasis. Nevertheless, the involvement of RAGE in the development and progression of oral squamous cell carcinomas has not been elucidated. This study investigated the expression of RAGE in ten oral squamous cell carcinoma cell lines including primary and metastatic cell lines and its association with invasion and metastasis.
METHODS: Reverse transcriptase-polymerase chain reaction, antisense phosphorothioate (S)-oligodeoxynucleotide assay, preparation of antibody, immunohistochemical staining, immunoblot analysis, migration assay, in vitro invasion assay, and wound-healing assay were used.
RESULTS: RAGE protein expression of metastatic cancer cells treated with RAGE antisense S-oligodeoxynucleotide was significantly reduced compared to that of sense S-oligodeoxynucleotide-treated cells. The migration assay showed that invasive activity was significantly reduced in metastatic cancer cells treated with RAGE antisense S-oligodeoxynucleotide. Similarly, during invasion assays, numbers of invading cells were also reduced with the addition of RAGE antisense S-oligodeoxynucleotide-treated cells. A wound-healing assay showed that only a few RAGE antisense S-oligodeoxynucleotide-treated cancer cells migrated into the scraped area, whereas sense S-oligodeoxynucleotide-treated cells showed many budding nests in the scraped area of the metastatic cell lines. Immunohistochemically, oral squamous cell carcinoma cells in the tumour mesenchymal border were often immunopositive, whereas basal cells in the normal mucosa were scarcely positive.
CONCLUSIONS: These results suggest that RAGE expression appears to be closely associated with the invasiveness of oral squamous cell carcinoma and represents a promising candidate for assessing the future therapeutic potential in treating patients with oral carcinoma. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127291     DOI: 10.1159/000087910

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  22 in total

Review 1.  Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Jun-Ichi Takino; Kentaro Nagamine; Takamitsu Hori; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Hepatol       Date:  2015-10-18

2.  HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression.

Authors:  Yanmei Li; Ping Wang; Jia Zhao; Haonan Li; Dahai Liu; Wei Zhu
Journal:  Mol Cell Biochem       Date:  2017-03-11       Impact factor: 3.396

3.  Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitro.

Authors:  Shun-Yao Ko; Hshin-An Ko; Tzong-Ming Shieh; Tzong-Cherng Chi; Hong-I Chen; Yi-Ting Chen; Ya-Hui Yu; Shu-Han Yang; Shu-Shing Chang
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

4.  Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet.

Authors:  Takasumi Shimomoto; Yi Luo; Hitoshi Ohmori; Yoshitomo Chihara; Kiyomu Fujii; Tomonori Sasahira; Ayumi Denda; Hiroki Kuniyasu
Journal:  J Gastroenterol       Date:  2012-03-31       Impact factor: 7.527

5.  Malondialdehyde-derived epitopes in human skin result from acute exposure to solar UV and occur in nonmelanoma skin cancer tissue.

Authors:  Joshua D Williams; Yira Bermudez; Sophia L Park; Steven P Stratton; Koji Uchida; Craig A Hurst; Georg T Wondrak
Journal:  J Photochem Photobiol B       Date:  2014-02-12       Impact factor: 6.252

6.  Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products.

Authors:  Jun-Ichi Takino; Sho-Ichi Yamagishi; Masayoshi Takeuchi
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

7.  Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells.

Authors:  K Fujii; Y Luo; T Sasahira; A Denda; H Ohmori; H Kuniyasu
Journal:  Cell Prolif       Date:  2009-07-06       Impact factor: 6.831

8.  Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy.

Authors:  Ayshamgul Hasim; Mayinuer Ali; Batur Mamtimin; Jun-Qi Ma; Qiao-Zhi Li; Abulizi Abudula
Journal:  Exp Ther Med       Date:  2012-03-12       Impact factor: 2.447

Review 9.  Certainty of S100 from Physiology to Pathology.

Authors:  Puneeth Horatti Kuberappa; Bhavana Shivanand Bagalad; Anuradha Ananthaneni; Md Asif Kiresur; Guduru Vijay Srinivas
Journal:  J Clin Diagn Res       Date:  2016-06-01

10.  Early stage diagnosis of oral cancer using 1H NMR-based metabolomics.

Authors:  Stefano Tiziani; Victor Lopes; Ulrich L Günther
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.